Literature DB >> 11836435

Mutant tax protein from bovine leukemia virus with enhanced ability to activate the expression of c-fos.

Shigeru Tajima1, Yoko Aida.   

Abstract

Bovine leukemia virus (BLV) is the etiologic agent of enzootic bovine leukosis. We previously identified several mutants of the BLV Tax protein with an ability to transactivate transcription via the BLV enhancer that is significantly greater than that of the wild-type Tax protein. Moreover, the mutant proteins also activated other viral enhancers, such as the enhancer of human T-cell leukemia virus type 1, which cannot be activated by wild-type BLV Tax. In this study, we demonstrated that the mutant proteins but not wild-type protein activate the upstream sequence of the human c-fos gene, which contains two major cis-acting elements, the CArG box and cyclic AMP-responsive element (CRE) motif. The mutant protein also strongly increased levels of endogenous c-fos mRNA in both human and bovine cell lines. On the other hand, the wild-type Tax protein has no activity to activate the expression of human c-fos, indicating that wild-type BLV Tax might discriminate between human and bovine c-fos promoter sequences. Deletion and point-mutational analysis of the cis-acting elements revealed that both the CArG box and the CRE motif were indispensable for the activation of c-fos by the mutant BLV Tax protein. Our results suggest that the mutant BLV Tax proteins might not only have the ability to enhance the production of virus particles but might also have increased ability to induce leukemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836435      PMCID: PMC135937          DOI: 10.1128/jvi.76.5.2557-2562.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  The serum and TPA responsive promoter and intron-exon structure of EGR2, a human early growth response gene encoding a zinc finger protein.

Authors:  V M Rangnekar; A C Aplin; V P Sukhatme
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

Review 2.  Molecular biology of HTLV-I: recent progress.

Authors:  M Yoshida
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996

3.  Transcriptional regulation of the murine urokinase-type plasminogen activator gene in skeletal myoblasts.

Authors:  F Miralles; I Ibáñez-Tallon; M Parra; M Crippa; F Blasi; D Besser; Y Nagamine; P Muñoz-Cánoves
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

4.  Human cysteine dioxygenase gene: structural organization, tissue-specific expression and downregulation by phorbol 12-myristate 13-acetate.

Authors:  N Tsuboyama-Kasaoka; Y Hosokawa; H Kodama; A Matsumoto; J Oka; M Totani
Journal:  Biosci Biotechnol Biochem       Date:  1999-06       Impact factor: 2.043

5.  Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.

Authors:  J Fujisawa; M Seiki; T Kiyokawa; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses.

Authors:  N Sagata; T Yasunaga; J Tsuzuku-Kawamura; K Ohishi; Y Ogawa; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways.

Authors:  K Matsumoto; H Shibata; J I Fujisawa; H Inoue; A Hakura; T Tsukahara; M Fujii
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers.

Authors:  S Tajima; Y Aida
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.

Authors:  R Grassmann; S Berchtold; I Radant; M Alt; B Fleckenstein; J G Sodroski; W A Haseltine; U Ramstedt
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway.

Authors:  T Akagi; K Shimotohno
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  8 in total

1.  Latency of viral expression in vivo is not related to CpG methylation in the U3 region and part of the R region of the long terminal repeat of bovine leukemia virus.

Authors:  Shigeru Tajima; Masako Tsukamoto; Yoko Aida
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo.

Authors:  Shigeru Tajima; Masahiko Takahashi; Shin-Nosuke Takeshima; Satoru Konnai; Shan Ai Yin; Shinobu Watarai; Yoshimasa Tanaka; Misao Onuma; Kosuke Okada; Yoko Aida
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  Identification of bovine leukemia virus tax function associated with host cell transcription, signaling, stress response and immune response pathway by microarray-based gene expression analysis.

Authors:  Mariluz Arainga; Eri Takeda; Yoko Aida
Journal:  BMC Genomics       Date:  2012-03-28       Impact factor: 3.969

4.  A new genotype of bovine leukemia virus in South America identified by NGS-based whole genome sequencing and molecular evolutionary genetic analysis.

Authors:  Meripet Polat; Shin-Nosuke Takeshima; Kazuyoshi Hosomichi; Jiyun Kim; Taku Miyasaka; Kazunori Yamada; Mariluz Arainga; Tomoyuki Murakami; Yuki Matsumoto; Veronica de la Barra Diaz; Carlos Javier Panei; Ester Teresa González; Misao Kanemaki; Misao Onuma; Guillermo Giovambattista; Yoko Aida
Journal:  Retrovirology       Date:  2016-01-12       Impact factor: 4.602

Review 5.  Epidemiology and genetic diversity of bovine leukemia virus.

Authors:  Meripet Polat; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Virol J       Date:  2017-11-02       Impact factor: 4.099

6.  A sensitive luminescence syncytium induction assay (LuSIA) based on a reporter plasmid containing a mutation in the glucocorticoid response element in the long terminal repeat U3 region of bovine leukemia virus.

Authors:  Hirotaka Sato; Sonoko Watanuki; Lanlan Bai; Liushiqi Borjigin; Hiroshi Ishizaki; Yasunobu Matsumoto; Yuma Hachiya; Hiroshi Sentsui; Yoko Aida
Journal:  Virol J       Date:  2019-05-20       Impact factor: 4.099

Review 7.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

Review 8.  Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus.

Authors:  Yoko Aida; Hironobu Murakami; Masahiko Takahashi; Shin-Nosuke Takeshima
Journal:  Front Microbiol       Date:  2013-11-08       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.